MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0072769
Grindlays Pharmaceuticals Pvt Ltd - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹14.96 Cr
▲ 69% YoY
Net profit · FY 2025
₹13.77 Lakh
Net margin 0.9%
EBITDA · FY 2025
₹73.66 Lakh
EBITDA margin 4.9%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹5.86 Cr
Satisfied ₹9.6 Cr
Company age
41 yrs
Est. 1985
Employees · EPFO
12
Provident fund records
About Grindlays Pharmaceuticals Pvt Ltd
Data last updated:
Grindlays Pharmaceuticals Pvt Ltd is a private limited company based in Mumbai, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 04 September 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U99999MH1985PTC037368. Its GSTIN is 27AAACG1836D1Z0 (Maharashtra).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Ramkrishna Harishet Kolwankar (Managing Director) and Arti Ramkrishna Kolwankar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office Number 406 407 408 4th Floor Swastik Chambers Cst Road Chembur, Mumbai, Maharashtra, India – 400071.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.96 Cr, a growth of 69% compared to the previous year. For the same year it recorded a net profit of ₹13.77 Lakh (net margin 0.9%) and EBITDA of ₹73.66 Lakh (EBITDA margin 4.9%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years and 5% over five years.
The company has about 12 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Grindlays Pharma. As per MCA filings, the company has open charges of ₹5.86 Cr and satisfied charges of ₹9.6 Cr on record. Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending.
Grindlays Pharmaceuticals Pvt Ltd is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0072769). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website grinpharma.com.
Company details
CIN U99999MH1985PTC037368
Registration Number 037368
Incorporation Date 04 September 1985
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-19-0072769
Key People
Ramkrishna Harishet Kolwankar Managing Director Arti Ramkrishna Kolwankar Director Santosh Ramkrishna Kolwankar Director Recognitions & Rankings of Grindlays Pharmaceuticals
Contact details
Grindlays Pharmaceuticals Pvt Ltd's registered office is in Mumbai, Maharashtra. Its website is grinpharma.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressOffice Number 406 407 408 4th Floor Swastik Chambers Cst Road Chembur, Mumbai, Maharashtra, India – 400071
- IndustryPharma, API Manufacturers, Drug Formulation & Development
To see the full contact details of Grindlays Pharmaceuticals Pvt Ltd, buy the company report.
Comprehensive company report
Grindlays Pharmaceuticals Pvt Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Grindlays Pharmaceuticals operates one associated brand: Grindlays Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures bulk drugs and drug intermediates for the pharmaceutical industry. | grinpharma.com |
Business activity
The main business activity of Grindlays Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Grindlays Pharmaceuticals Pvt Ltd, buy the company report.
Financials of Grindlays Pharmaceuticals Pvt Ltd
FY 2025 filings availableGrindlays Pharmaceuticals Pvt Ltd reported revenue of ₹14.96 Cr (up 69% YoY) for FY 2025.
Revenue · FY 2025
₹14.96 Cr ▲ 69%
Net profit · FY 2025
₹13.77 Lakh margin 0.9%
EBITDA · FY 2025
₹73.66 Lakh margin 4.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 69%
3 years · compounded
▼ 14%
5 years · compounded
▼ 5%
EBITDA CAGR growth
1 year
▲ 15%
3 years · compounded
▼ 31%
5 years · compounded
▼ 14%
Revenue rose 69% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 5%. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹73.66 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13.77 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.9% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Grindlays Pharmaceuticals Pvt Ltd, buy the company report.
Board of directors of Grindlays Pharmaceuticals Pvt Ltd
Grindlays Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arti Ramkrishna Kolwankar Also directs: Ferico Laboratories LLP | Director | 01 Apr 1997 | 29 Years 7 Months | Current |
| Ramkrishna Harishet Kolwankar Also directs: Ferico Laboratories LLP | Managing Director | 15 Oct 1985 | 41 Years 0 Months | Current |
| Santosh Ramkrishna Kolwankar Also directs: Chiplun Fine Chemicals Private Limited | Director | 16 Nov 2009 | 16 Years 11 Months | Current |
| Dhanashri Girish Gudi | Director | 31 Mar 1995 | 31 Years 7 Months | Current |
Peer comparison
Grindlays Pharmaceuticals Pvt Ltd is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers, Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kras Pharmaceuticals Private Limited | ₹15.05 Cr (FY 2025) | 45.0% | Fatuha, Bihar, India | |||
| Kansas Laboratories Pvt Ltd | ₹15.04 Cr (FY 2025) | 13.0% | Kolkata, West Bengal, India | |||
| Cyma Life Sciences Private Limited | ₹15.02 Cr (FY 2024) | -6.0% | Hyderabad, Telangana, India | |||
| Rasino Drugs Private Limited | ₹14.98 Cr (FY 2024) | -9.0% | Ambernath, Maharashtra, India | |||
| Grindlays Pharmaceuticals Pvt Ltdthis company | ₹14.96 Cr (FY 2025) | ₹13.77 Lakh | 0.9% | 69.0% | 12 | Mumbai, Maharashtra, India |
| Santexo Pharma Private Limited | ₹14.95 Cr (FY 2025) | 86.0% | New Delhi, Delhi, India | |||
| Revive Formulations India Private Limited | ₹14.93 Cr (FY 2024) | 5.0% | Vanur, Tamil Nadu, India | |||
| Theo Pharma Pvt Ltd | ₹14.91 Cr (FY 2025) | 26.0% | Ahmedabad, Gujarat, India | |||
| Raymed Pharmaceuticals Limited | ₹14.9 Cr (FY 2025) | -2.0% | Chandigarh, India |
To see the full peer comparison of Grindlays Pharmaceuticals Pvt Ltd, buy the company report.
Auditor
Grindlays Pharmaceuticals Pvt Ltd is audited by KARIA & SHAH for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KARIA & SHAH | FY 2022 | 112203W |
Shareholding
The shareholding of Grindlays Pharmaceuticals Pvt Ltd is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Grindlays Pharmaceuticals Pvt Ltd, buy the company report.
Charges & borrowings
Open charges
₹5.86 Cr
Satisfied charges
₹9.6 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Sep 2008 | 10129800 | Bank of India | ₹5.86 Cr | Open | |
| 31 Jul 2013 | 10448577 | Deutsche Bank Ag | ₹3.55 Cr | Satisfied | |
| 18 Mar 2009 | 10151901 | Bank of India | ₹12 Lakh | Satisfied | |
| 27 Sep 2008 | 10129799 | Bank of India | ₹3.5 Cr | Satisfied | |
| 02 Aug 2004 | 90214119 | Bank of India | ₹1.9 Cr | Satisfied |
To see the full charge records of Grindlays Pharmaceuticals Pvt Ltd, buy the company report.
Total charge records: 8 View all charges
Legal cases
Grindlays Pharmaceuticals Pvt Ltd has 2 court cases on record: 2 filed against it. 1 case is pending and 1 is disposed.
Total cases
2
Filed against the company
2
Pending
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Raigad, Maharashtra | Court case (Spl. Case Drug Cosm.) | Filed against the company | Pending |
| District court, Raigad, Maharashtra | Court case (Spl. Case Drug Cosm.) | Filed against the company by The State of Maharashtra THR. N.M.Gandhi Drugs Inspector | Disposed |
To see the full case history of Grindlays Pharmaceuticals Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Grindlays Pharmaceuticals Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Grindlays Pharmaceuticals Pvt Ltd has a workforce of 12 employees on its EPFO records as of Apr 01, 2024, across 1 active EPFO establishment.
Employee count
12
Active EPFO establishments
1
Employee growth
9.09%
GST
Grindlays Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACG1836D1Z0 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Grindlays Pharmaceuticals Pvt Ltd, buy the company report.
Recent activity
Grindlays Pharmaceuticals Pvt Ltd has 5 board changes on record since 1985: 4 appointments and 1 cessation. The latest: Santosh Ramkrishna Kolwankar ceased to be Additional Director on 30 Sep 2014.
AGM
Grindlays Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Grindlays Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
A charge registered on 18 Mar 2009 via Charge ID 10151901 with Bank Of India was fully satisfied on 14 Dec 2020.
Charges
A charge registered on 27 Sep 2008 via Charge ID 10129799 with Bank Of India was fully satisfied on 14 Dec 2020.
Charges
A charge registered on 02 Aug 2004 via Charge ID 90214119 with Bank Of India was fully satisfied on 14 Dec 2020.
Charges
A charge registered on 31 Jul 2013 via Charge ID 10448577 with Deutsche Bank Ag was fully satisfied on 19 Nov 2020.
Charges
A charge with Bank Of India of Rs. 5.86 Cr registered on 27 Sep 2008 with Charge ID 10129800 was modified on 19 Jun 2020.
Charges
A charge with Bank Of India of Rs. 3.50 Cr registered on 27 Sep 2008 with Charge ID 10129799 was modified on 21 Nov 2014.
Ceased
Santosh Ramkrishna Kolwankar ceased to be Additional Director.
Charges
A charge with Deutsche Bank Ag amounted to Rs. 3.55 Cr with Charge ID 10448577 was registered on 31 Jul 2013.
Appointed
Santosh Ramkrishna Kolwankar was appointed as Director.
Charges
A charge registered on 20 Sep 2000 via Charge ID 90213607 with State Bank Of India was fully satisfied on 22 Jun 2009.
17 earlier events are in the company report.
Frequently asked questions
Grindlays Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 04 September 1985 (41+ years old) and is registered under CIN U99999MH1985PTC037368.
Grindlays Pharmaceuticals has 4 current directors:
- Ramkrishna Harishet Kolwankar - Managing Director
- Arti Ramkrishna Kolwankar - Director
- Santosh Ramkrishna Kolwankar - Director
- Dhanashri Girish Gudi - Director
The latest financial statements of Grindlays Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Grindlays Pharmaceuticals is 27AAACG1836D1Z0, registered in Maharashtra.
The CIN (Corporate Identification Number) of Grindlays Pharmaceuticals is U99999MH1985PTC037368. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Grindlays Pharmaceuticals has 2 court cases on record: 2 filed against it. 1 is pending.
Grindlays Pharmaceuticals was incorporated on 04 September 1985, making it 41+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Grindlays Pharmaceuticals by revenue are Kras Pharmaceuticals Private Limited, Kansas Laboratories Pvt Ltd, Cyma Life Sciences Private Limited, Rasino Drugs Private Limited, Santexo Pharma Private Limited and 3 more, all in the Pharma industry (API Manufacturers, Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Santosh Ramkrishna Kolwankar ceased to be Additional Director on 30 Sep 2014. Santosh Ramkrishna Kolwankar was appointed as Director on 16 Nov 2009. Arti Ramkrishna Kolwankar was appointed as Director on 01 Apr 1997. Grindlays Pharmaceuticals has 5 board changes on record in total.
Yes, Grindlays Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-MH-19-0072769).
Grindlays Pharmaceuticals can be reached through the website grinpharma.com. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages